Accessibility Menu
 

Artrya

(ASX) AYA

Current Price$4.74
Market Cap$731.88M
Since IPO (2021)+200%
5 YearN/A
1 Year+532%
1 Month+14%

Artrya Financials at a Glance

Market Cap

$731.88M

Revenue (TTM)

$42.00K

Net Income (TTM)

$34.27M

EPS (TTM)

$-0.17

P/E Ratio

-26.63

Dividend

$0.00

Beta (Volatility)

-0.26 (Low)

Price

$4.74

Volume

214,719

Open

$4.67

Previous Close

$4.74

Daily Range

$4.61 - $4.80

52-Week Range

$0.60 - $5.24

AYA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Artrya

Industry

Health Care Technology

CEO

Mathew Regan

Headquarters

West Perth, WA 6005, AU

AYA Financials

Key Financial Metrics (TTM)

Gross Margin

-434%

Operating Margin

-757%

Net Income Margin

-680%

Return on Equity

-38%

Return on Capital

-24%

Return on Assets

-21%

Earnings Yield

-3.76%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$731.88M

Shares Outstanding

159.80M

Volume

214.72K

Avg. Volume

462.63K

Financials (TTM)

Gross Profit

$15.99M

Operating Income

$16.62M

EBITDA

$16.21M

Operating Cash Flow

$14.27M

Capital Expenditure

$263.00K

Free Cash Flow

$14.53M

Cash & ST Invst.

$11.33M

Total Debt

$624.00K

Artrya Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$14.00K

N/A

Gross Profit

$609.00K

+38.4%

Gross Margin

-43.50%

N/A

Market Cap

$731.88M

N/A

Market Cap/Employee

$17.02M

N/A

Employees

43

N/A

Net Income

$10.74M

-212.3%

EBITDA

$12.23M

-109.8%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$76.12M

+430.6%

Accounts Receivable

$9.22M

+357.9%

Inventory

$0.00

N/A

Long Term Debt

$186.00K

-76.5%

Short Term Debt

$360.00K

-37.7%

Return on Assets

-21.38%

N/A

Return on Invested Capital

-24.44%

N/A

Free Cash Flow

$10.95M

-56.1%

Operating Cash Flow

$10.88M

-55.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AVR.AXAnteris Technologies Ltd
$12.91+2.95%
IMR.AXImricor Medical Systems, Inc.
$1.81-0.27%
CGS.AXCogstate Limited
$2.62+3.15%
PSQ.AXPacific Smiles Group Limited
$2.18+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NIONio
$5.60+0.00%
QBTSD-Wave Quantum
$25.74+0.33%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$14.72+0.00%
NOKNokia
$14.18+0.04%

Questions About AYA

What is the current price of Artrya?

Artrya is trading at A$4.74 per share.

What is the 52-week range for Artrya?

Over the past 52 weeks, Artrya has traded between A$0.61 and A$5.24.

How much debt does Artrya have?

As of the most recent reporting period, Artrya reported total debt of $624,000.

How much cash does Artrya have on hand?

Artrya reported $11.48M in cash and cash equivalents in its most recent financial results.

What is Artrya’s dividend yield?

Artrya does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.